Rintatolimod (Ampligen ® ) Enhances Numbers of Peripheral B Cells and Is Associated with Longer Survival in Patients with Locally Advanced and Metastasized Pancreatic Cancer Pre-Treated with FOLFIRINOX: A Single-Center Named Patient Program.
Hassana El HaddaouiRianne BroodDiba LatifiAstrid A OostvogelsYarne KlaverMiranda MoskieDana A M MustafaReno DebetsCasper H J van EijckPublished in: Cancers (2022)
Treatment with rintatolimod showed a favorable effect on the numbers of peripheral B cells in patients with pancreatic cancer and improved survival in pancreatic cancer, but additional evidence is required.